Piper Jaffray Reiterates Overweight Rating on Impax Labs

According to Piper Jaffray, Impax Laboratories

Overweight rating is reiterated. Piper Jaffray said that it met with Impax senior management yesterday, and came away with increased confidence that management is tracking to a timely resolution of the manufacturing issues at its Hayward, CA facility (i.e., before March 1). “We reiterate our Overweight rating and $32 price target.” Impax Laboratories closed yesterday at $19.92.